RSS

treatment

Laboratoris Sanifit has appointed Dr Preston S. Klassen, MD, MHS as its chief medical officer and announced the launch of its US Subsidiary, based in San Diego, USA. more

News

Researchers have found that a drug already approved for treatment for tuberculosis could also be a tool to combat another major disease of the developing world. more

News

Relmada Therapeutics, (RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, has announced the promotion of Michael D. Becker to chief financial officer more

News

A new Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus Life Sciences’ pharmaceutical grade L-glutamine treatment (PGLG). more

News

An artificial model, the HuMiX, ‘Human-Microbial X(cross)-talk’, has allowed research to be carried out based on the interaction between microorganisms in the gut and the human body. more

News

MyTomorrows and Spectrum Pharmaceuticals team up to provide access to liposome-encapsulated vincristine for the treatment of Philadelphia chromosome negative acute lymphoblastic leukaemia more

News

Dr Alexandre Akoulitchev, Oxford BioDynamics, talks to EPM about biomarkers aiding diagnostics and new treatments more

Opinion

With Halloween just around the corner EPM has compiled a list of gruesome medical remedies from yesteryear. No spoonful of sugar would have helped with this lot… more

News

Diseased cancer and tuberculosis cells to get improved delivery of therapeutic molecules more

News